BOSTON, MA (September 14, 2011) meQuilibrium, a provider of online stress management solutions for consumers and employers, today announced the close of $2.3 million in Series A financing. Chrysalis Ventures led the round, joined by RIME Communications Capital and individual investors. In conjunction with the financing, Chrysalis Principal Wright Steenrod has joined the company’s board of directors.
The investment will allow the company to commercialize its product and accelerate national sales efforts.
meQuilibrium is an online lifestyle management platform designed to provide a personalized experience for individuals to uncover, assess, and manage the stresses in their lives. The product will debut with a free stress tracker app that allows consumers to track and monitor patterns in stress and a more robust paid service that gives subscribers tools and exercises to assess and improve his or her resilience to stress based on a personalized stress profile and individual “meQ” score.
“Stress is the new fat,” said CEO Jan Bruce. “Consumers get it; businesses increasingly do too. Health practitioners cite stress as a leading cause of hypertension, diabetes, infertility, sleep disorders and gastrointestinal disease, not to mention lost productivity and low morale. The meQuilibrium approach combines the essentials of positive psychology and integrative health and makes stress management affordable and widely accessible through a digital model.”
Jan Bruce founded meQuilibrium in 2010 during her tenure as entrepreneur-in-residence at Chrysalis Ventures. An accomplished media executive in consumer lifestyle and health markets, she was most recently Managing Director of wholeliving.com and Whole Living/body+soul Magazine at Martha Stewart Living Omnimedia, which Ms. Bruce had sold to Martha Stewart Living in her capacity as CEO of the company that formerly owned those publications.
“We are thrilled to have the opportunity to partner with Jan Bruce in meQuilibrium,” said Wright Steenrod, Principal at Chrysalis Ventures. “We believe the meQuilibrium platform represents the next generation of digital consumer-centric wellness engagement tools and will help prevent significant healthcare costs through its revolutionary approach to stress management.”
About meQuilibrium
meQuilibrium, the operating name of New Life Solution, Inc., is a personalized, interactive system to manage stress and lifestyle which provides tools to measure stress levels, enhance emotional well-being and deliver measurable life improvement. Aimed at individuals as well as employers, the meQuilibrium program is based on clinical practice developed in 20 years of research by Chief Science Officer Dr. Andrew Shatté, a professor at the University of Arizona College of Medicine, and Chief Medical Officer Dr. Adam Perlman, Executive Director of Integrative Medicine at Duke University. meQuilibrium is headquartered in Boston. For more information, please visit www.mequilibrium.com.
About Chrysalis Ventures
Chrysalis Ventures manages one of Mid-America’s largest funds for early-stage and growth investments with approximately $400 million under management. Since 1993, the firm has invested in over 65 companies, primarily in the healthcare and technology sectors. With headquarters in Louisville, Kentucky, Chrysalis has offices in Cleveland, Pittsburgh, Ann Arbor and Houston. The firm seeks to partner with entrepreneurs to build enduring businesses in industries undergoing significant transformation. For more information, please visit www.chrysalisventures.com.